Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 132


LDL reduction is the major focus in the primary and secondary prevention of atherosclerotic CVD. In August, the American College of Cardiology published an expert consensus decision pathway on the role of nonstatin therapies, which provides very helpful new perspectives on appropriate degrees of LDL lowering in a variety of patients. This document builds upon the 2018 American Heart